Table of Contents
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis

PART 05: MARKET SIZING
• Market definition
• Market sizing
• Market size and forecast

PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT
• Segmentation by product
• Comparison by product
• Natural tissue scaffolds
• Synthetic tissue scaffolds
• Market opportunity by product

PART 08: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Musculoskeletal
• Dermatological
• Cardiovascular
• Others

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Tissue scaffolds market in Americas
• Tissue scaffolds market in EMEA
• Tissue scaffolds market in APAC
• Key leading countries
• Market opportunity by region

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges

PART 13: MARKET TRENDS
• Growing M&A and strategic collaborations
• Increasing technological advances

PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario

PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bioventus
• Integra Lifesciences
• MiMedx Group
• Organogenesis
• RTI Surgical
• Smith & Nephew
• Other prominent vendors

PART 16: APPENDIX
• List of abbreviations

[List of Exhibits]
Exhibit 01: Parent market
Exhibit 02: Global regenerative medicine market: Segmentation
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2017
Exhibit 18: Global tissue scaffolds market – Market share 2017-2022 (%)
Exhibit 19: Comparison by product
Exhibit 20: Global natural tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Global natural tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 22: Global synthetic tissue scaffolds market – Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Global synthetic tissue scaffolds market – Year over year growth 2018-2022 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Tissue scaffold market by application – Market share 2017-2022 (%)
Exhibit 26: Customer landscape
Exhibit 27: Global tissue scaffolds market – Market share by region 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Tissue scaffolds market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Tissue scaffolds market in Americas – Year over year growth 2018-2022 (%)
Exhibit 31: Top two countries in Americas
Exhibit 32: Tissue scaffolds market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Tissue scaffolds market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 34: Top two countries in EMEA
Exhibit 35: Tissue scaffolds market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Tissue scaffolds market in APAC – Year over year growth 2018-2022 (%)
Exhibit 37: Top two countries in APAC
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity by geography
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Competitive structure analysis of global tissue scaffolds market 2017
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Bioventus: Overview
Exhibit 47: Bioventus: Business segments
Exhibit 48: Bioventus: Organizational developments
Exhibit 49: Bioventus: Geographic focus
Exhibit 50: Bioventus: Segment focus
Exhibit 51: Bioventus: Key offerings
Exhibit 52: Bioventus: Key customers
Exhibit 53: Integra LifeSciences: Overview
Exhibit 54: Integra LifeSciences: Business segments
Exhibit 55: Integra LifeSciences: Organizational developments
Exhibit 56: Integra LifeSciences: Geographic focus
Exhibit 57: Integra LifeSciences: Segment focus
Exhibit 58: Integra LifeSciences: Key offerings
Exhibit 59: Integra LifeSciences: Key customers
Exhibit 60: MiMedx Group: Overview
Exhibit 61: MiMedx Group: Business segments
Exhibit 62: MiMedx Group: Organizational developments
Exhibit 63: MiMedx Group: Geographic focus
Exhibit 64: MidMedx Group: Segment focus
Exhibit 65: MidMedx Group: Key offerings
Exhibit 66: MiMedx Group: Key customers
Exhibit 67: Organogenesis: Overview
Exhibit 68: Organogenesis: Business segments
Exhibit 69: Organogenesis: Organizational developments
Exhibit 70: Organogenesis: Geographic focus
Exhibit 71: Organogenesis: Segment focus
Exhibit 72: Organogenesis: Key offerings
Exhibit 73: Organogenesis: Key customers
Exhibit 74: RTI Surgical: Overview
Exhibit 75: RTI Surgical: Business segments
Exhibit 76: RTI Surgical: Organizational developments
Exhibit 77: RTI Surgical: Geographic focus
Exhibit 78: RTI Surgical: Segment focus
Exhibit 79: RTI Surgical: Key offerings
Exhibit 80: RTI Surgical: Key customers
Exhibit 81: Smith & Nephew: Overview
Exhibit 82: Smith & Nephew: Business segments
Exhibit 83: Smith & Nephew: Organizational developments
Exhibit 84: Smith & Nephew: Geographic focus
Exhibit 85: Smith & Nephew: Segment focus
Exhibit 86: Smith & Nephew: Key offerings
Exhibit 87: Smith & Nephew: Key customers